「Monoclonal」の共起表現一覧(1語右で並び替え)
該当件数 : 197件
| U.S. Patent 6,399,063 - | Monoclonal antibodies directed to the HER2 receptor |
| U.S. Patent 5,772,997 - | Monoclonal antibodies directed to the HER2 receptor |
| Monoclonal antibodies can distinguish between type A an | |
| Monoclonal antibodies are potential substances for this | |
| awarded the 1984 Nobel Prize for his work on | monoclonal antibodies |
| CD5 was used as a T-cell marker until | monoclonal antibodies against CD3 were developed. |
| By contrast, | monoclonal antibodies are derived from a single cell li |
| fixation permits the detection and typing of | monoclonal antibodies or immunoglobulins in serum or ur |
| Monoclonal antibodies are made in the laboratory and ca | |
| e were used extensively in the production of | monoclonal antibodies (MAbs). |
| it a suitable target for immunotherapy with | monoclonal antibodies or with artificial T cell recepto |
| Monoclonal antibodies are monospecific, but monospecifi | |
| tigen-binding (Fab or Fab') of two different | monoclonal antibodies and are linked by chemical means |
| The term aritox occurs in names of | monoclonal antibodies and indicates that they are linke |
| s can be screened for by flow cytometry with | monoclonal antibodies to CD18 or to CD11a, b, or c. |
| 2009, there are two fully human anti CTLA-4 | monoclonal antibodies in advanced clinical trials, trem |
| from applying recombinant DNA technology to | monoclonal antibodies and inspired the development of t |
| He is best known for his work on therapeutic | monoclonal antibodies and their use to achieve toleranc |
| intended for the classification of the many | monoclonal antibodies (mAbs) generated by different lab |
| The stem -mab is used for | monoclonal antibodies as well as for their fragments, a |
| Main article: | Monoclonal antibodies#Production |
| r bispecific antibodies, and unlike ordinary | monoclonal antibodies, BiTEs form a link between T cell |
| Unlike | monoclonal antibodies, which are often produced in mamm |
| tract Manufacturing Organization or (CMO) of | monoclonal antibodies, recombinant proteins and vaccine |
| experimental drug development using blocking | monoclonal antibodies, therapeutic vaccines, or siRNA t |
| of different capture agents, most frequently | monoclonal antibodies, are deposited on a chip surface |
| hniques had been developed: recombinant DNA, | monoclonal antibodies, and gene expression, the foundat |
| Anticalins are being used in lieu of | monoclonal antibodies, but are about eight times smalle |
| Compared to other anti-HER2 | monoclonal antibodies, the Fc domain of MGAH22 is optim |
| e one taken in the development of bispecific | monoclonal antibodies. |
| e species marker antigens for development of | monoclonal antibodies. |
| munologist known for his work on therapeutic | monoclonal antibodies. |
| ells for cancer therapy, cancer vaccines and | monoclonal antibodies. |
| Foravirumab is a | monoclonal antibody for the prophylaxis of rabies. |
| Bertilimumab is a human | monoclonal antibody that binds to eotaxin-1. |
| It is a | monoclonal antibody which blocks interleukin 13. |
| Faralimomab is a mouse | monoclonal antibody and an immunomodulator. |
| Lumiliximab is a | monoclonal antibody that targets CD23. |
| Clenoliximab (INN) is a | monoclonal antibody against CD4. |
| Omalizumab is a glycosylated | monoclonal antibody expressed by mammalian cells. |
| Rontalizumab is a humanized | monoclonal antibody being developed by Genentech. |
| Felvizumab is a humanized | monoclonal antibody against respiratory syncytial virus |
| CA-125 was initially detected using the | monoclonal antibody designated OC125. |
| Anti-mesothelin | monoclonal antibody MORAb-009 is a monoclonal antibody |
| Anti-TGF-beta | monoclonal antibody GC1008 is a monoclonal antibody bei |
| umab (proposed USAN) is a chimeric/humanized | monoclonal antibody and an immunosuppressive drug. |
| Minretumomab is a mouse | monoclonal antibody designed for the treatment of cance |
| chnetium (99mTc) pintumomab (INN) is a mouse | monoclonal antibody for the imaging of adenocarcinoma. |
| Like the | monoclonal antibody belimumab, atacicept blocks the bin |
| Trastuzumab (INN; trade name Herceptin) is a | monoclonal antibody that interferes with the HER2/neu r |
| Galiximab is a | monoclonal antibody designed for the treatment of B-cel |
| The fully-human | monoclonal antibody glembatumumab (CR011) is linked to |
| Vitaxin is a humanized | monoclonal antibody against the vascular integrin avb3. |
| Anatumomab mafenatox is a mouse | monoclonal antibody for the treatment non-small cell lu |
| Veltuzumab is a | monoclonal antibody which is being investigated for the |
| y used to fuse B-cells with myeloma cells in | monoclonal antibody production. |
| Inolimomab is a mouse | monoclonal antibody developed as an immunosuppressive d |
| Her early work involved the application of | monoclonal antibody technology to questions within neur |
| Fresolimumab is a human | monoclonal antibody and an immunomodulator, developed b |
| otuzumab ozogamicin (CMC-544) is a humanized | monoclonal antibody for the treatment of cancers. |
| Lebrikizumab is a humanized | monoclonal antibody and an immunosuppresive drug for th |
| It is a IgG2a anti-CD20 | monoclonal antibody derived from immortalized mouse cel |
| Teplizumab is a | monoclonal antibody which is used as an immunosuppressi |
| Teplizumab is a humanized Fc-engineered | monoclonal antibody also known as MGA031 and hOKT3γ1(Al |
| Sibrotuzumab is a humanized | monoclonal antibody intended for the treatment of cance |
| Talizumab (TNX-901) is a humanized | monoclonal antibody being developed by Tanox in Houston |
| Certolizumab pegol is a | monoclonal antibody directed against tumor necrosis fac |
| Elsilimomab (also known as B-E8) is a mouse | monoclonal antibody and an immunosuppressive drug. |
| Lintuzumab (SGN-33) is a humanized | monoclonal antibody used in the treatment of cancer. |
| Tigatuzumab (CS-1008) is a | monoclonal antibody for the treatment of cancer. |
| Pritumumab is a human | monoclonal antibody used in the treatment of brain canc |
| Telimomab aritox is a mouse | monoclonal antibody which is an immunosuppressive drug. |
| tuzumab (formerly EMD 72000) was a humanized | monoclonal antibody for the treatment of cancer. |
| The | monoclonal antibody tefibazumab targets ClfA and has be |
| Adecatumumab (MT201) is a recombinant human | monoclonal antibody which is used to target tumor cells |
| Panobacumab (proposed INN) is a | monoclonal antibody designed as an antibacterial agains |
| Toralizumab (IDEC 131) was a humanized | monoclonal antibody and an immunosuppressive drug. |
| Pascolizumab is a humanized | monoclonal antibody for the treatment of asthma. |
| Urtoxazumab is a humanized | monoclonal antibody against diarrhoea caused by Escheri |
| Keliximab is a | monoclonal antibody for the treatment of severe chronic |
| erimental name of an anti-HER2/neu targeting | monoclonal antibody developed by MacroGenics. |
| Its mechanism of action is similar to the | monoclonal antibody trastuzumab. |
| Gomiliximab is a | monoclonal antibody acting as an immunosuppressive drug |
| and their research team first isolated this | monoclonal antibody in 1981. |
| esilesomab (trade name Scintimun) is a mouse | monoclonal antibody labelled with the radioactive isoto |
| e (125I) CC49 is an iodine-125 radiolabelled | monoclonal antibody for the detection of tumours. |
| Tanezumab (INN, codenamed RN624) is a | monoclonal antibody against nerve growth factor. |
| Tadocizumab is a humanized | monoclonal antibody that acts on the cardiovascular sys |
| w BMS-945429) is an aglycosylated, humanized | monoclonal antibody against interleukin-6. |
| Taplitumomab paptox is a mouse | monoclonal antibody designed for the treatment of cance |
| Nerelimomab is a mouse | monoclonal antibody acting as a TNF inhibitor. |
| Libivirumab is a human | monoclonal antibody directed against the hepatitis B vi |
| Gantenerumab is a | monoclonal antibody for the treatment of Alzheimer's di |
| CD32B may also be a target for | monoclonal antibody therapy for malignancies., |
| Vepalimomab is a mouse | monoclonal antibody developed for the treatment of infl |
| Tenatumomab is a | monoclonal antibody designed for the treatment of cance |
| Lemalesomab is a mouse | monoclonal antibody for the diagnosis of inflammatory l |
| cilimumab, CP-675,206) is a fully human IgG2 | monoclonal antibody produced by Pfizer. |
| It is a fusion protein of a humanized | monoclonal antibody (tucotuzumab) and an interleukin-2 |
| monoclonal antibody therapy- e.g., mepoluzimab or resli | |
| ) imciromab (trade name Myoscint) is a mouse | monoclonal antibody labelled with the radioisotope Indi |
| ibutions to improvements and developments in | monoclonal antibody technology-especially focusing on t |
| Sevirumab (MSL-109) is a human | monoclonal antibody for the treatment of infections wit |
| under the trade name LymphoScan) is a mouse | monoclonal antibody labelled with the radioactive isoto |
| Pagibaximab is a chimeric | monoclonal antibody for the prevention of staphylococca |
| It is a single chain variable fragment of a | monoclonal antibody targeted against component 5 of the |
| Ramucirumab is a fully-human | monoclonal antibody (IgG1) directed against the Vascula |
| gis which is manufactured by MedImmune) is a | monoclonal antibody produced by recombinant DNA technol |
| (trade name Rexomun) is a rat-murine hybrid | monoclonal antibody designed to treat some types of can |
| Cantuzumab mertansine is a humanized | monoclonal antibody used to treat colorectal cancer and |
| the trade name CEA-CIDE) is a humanized IgG1 | monoclonal antibody for the treatment of colorectal can |
| is a Fab' fragment of IMMU-4, a murine IgG1 | monoclonal antibody extracted from the ascites of mice. |
| Lerdelimumab (CAT-152) is a human | monoclonal antibody and an immunosuppressive drug devel |
| Afutuzumab is a | monoclonal antibody being developed by Hoffmann-La Roch |
| Monoclonal antibody technology combined with recombinan | |
| wn as LeukArrest and Hu23F2G, is a humanized | monoclonal antibody which was an experimental immunosup |
| The drug is a | monoclonal antibody that suppresses white blood cells w |
| is a recombinant DNA-derived humanized IgG1k | monoclonal antibody that selectively binds to human imm |
| Solanezumab (proposed INN) is a | monoclonal antibody being investigated as a neuroprotec |
| Olaratumab is a | monoclonal antibody which is being developed by Imclone |
| eted under the trade name OvaRex) is a mouse | monoclonal antibody it binds to the antigen CA125, a ca |
| under the brand name Aurexis) is a humanized | monoclonal antibody for the treatment of severe infecti |
| Edobacomab, codenamed E5, is a mouse | monoclonal antibody that was investigated as a possible |
| She pioneered the use of | monoclonal antibody technology in brain research and di |
| The | monoclonal antibody (for CD22) is linked to a cytotoxic |
| proposed trade name Bosatria) is a humanized | monoclonal antibody that recognizes interleukin-5 (IL-5 |
| Golimumab (CNTO 148) is a human | monoclonal antibody which is used as an immunosuppressi |
| Anti-mesothelin | monoclonal antibody MORAb-009 binds to mesothelin (a pr |
| preclinical studies of its agent Angiolix, a | monoclonal antibody that binds to lactadherin and inhib |
| so known as ETR2-ST01) is an agonistic human | monoclonal antibody against TRAIL-R2 (DR5, APO-2) used |
| and Drug Administration (FDA) approved human | monoclonal antibody developed by Bristol-Myers Squibb, |
| Iratumumab is a human | monoclonal antibody used in the treatment of oncologica |
| so known as SGN-40 or huS2C6) is a humanized | monoclonal antibody being developed for the treatment o |
| known as TNX-355) is a non-immunosuppressive | monoclonal antibody that binds CD4, the primary recepto |
| Abagovomab is a mouse anti-idiotype | monoclonal antibody whose variable epitope mirrors a tu |
| lociximab (also known as M200) is a chimeric | monoclonal antibody jointly developed by PDL BioPharma |
| Lucatumumab is a human | monoclonal antibody being investigated for the treatmen |
| ly human Vascular Adhesion Protein-1 (VAP-1) | monoclonal antibody - intended for treatment of inflamm |
| it is a single chain variable fragment of a | monoclonal antibody which binds to epithelial cell adhe |
| Kim L. O'Neill is the developer of a | monoclonal antibody that allows for the accurate, cheap |
| ntetate (trade name Hybri-ceaker) is a mouse | monoclonal antibody linked to pentetate which acts as a |
| rzerra, also known as HuMax-CD20) is a human | monoclonal antibody (for the CD20 protein) which appear |
| to HER2 on the tumor cell surface, anti-HER2 | monoclonal antibody MGAH22 may induce an antibody-depen |
| A Fc-domain optimized IgG | monoclonal antibody directed against the human epiderma |
| ade name Zenapax) is a therapeutic humanized | monoclonal antibody to the alpha subunit of the IL-2 re |
| Kenney had managed the | monoclonal antibody (McAb) development laboratory for S |
| mab A/S, both of which develop drugs used in | monoclonal antibody therapy. |
| nd Drug Administration approval of the first | monoclonal antibody drug, Muronomab-CD3 (also known as |
| Citatuzumab bogatox (VB6-845) is a | monoclonal antibody Fab fragment fused with bouganin, a |
| Tuvirumab is a human | monoclonal antibody for the treatment of patients with |
| Mitumomab (BEC-2) is a mouse | monoclonal antibody investigated for the treatment of s |
| uplizumab (trade name Antova) is a humanized | monoclonal antibody intended for the treatment of rheum |
| vilimomab (also known as ABX-CBL) is a mouse | monoclonal antibody intended for use as an immunosuppre |
| It was the Fab' fragment of a mouse | monoclonal antibody labelled with the radioisotope indi |
| It consisted of an intact murine (mouse) IgM | monoclonal antibody against human CD15, labeled with te |
| Reslizumab is a humanized | monoclonal antibody intended for the treatment of eosin |
| PRO 140 is a humanized | monoclonal antibody targeted against the CCR5 receptor |
| Specific diagnosis is made through | monoclonal antibody testing for CR3, one of the three c |
| ment of Genentech's bevacizumab and Lucentis | monoclonal antibody treatments. |
| Compared to other | monoclonal antibody treatments (many of which are well |
| ncer that the efficacy of treatment with the | monoclonal antibody cetuximab can be assessed by the ex |
| oduced by Genmab, as well as the first human | monoclonal antibody which targets the CD20 molecule tha |
| t the University of Pennsylvania showed that | monoclonal antibody specific to myostatin improves the |
| ott Laboratories) is a fully human TNF-alpha | monoclonal antibody approved for the treatment of rheum |
| rade name Panorex) is a chimeric mouse/human | monoclonal antibody to the cell-surface glycoprotein Ep |
| Metelimumab (CAT-192) is a human IgG4 | monoclonal antibody that neutralizes TGF beta 1 which h |
| olecule of the drug consists of the chimeric | monoclonal antibody brentuximab (which targets CD30) an |
| Zolimomab aritox is a mouse | monoclonal antibody which has been investigated for the |
| The anti-TNF | monoclonal antibody biologics, Infliximab and adalimuma |
| sted that the protein may cross-react with a | monoclonal antibody that recognizes the phosphatidylser |
| scleroderma showed the human anti-TGF-Beta1 | monoclonal antibody to be safe and well tolerated acros |
| % of neurons became immunoreactive to 1C2 (a | monoclonal antibody against expanded polyglutamine stre |
| is a combination of bivatuzumab, a humanized | monoclonal antibody, and mertansine, a cytotoxic agent. |
| ), which was identified by reactivity with a | monoclonal antibody, is present on monocytes, neutrophi |
| Epratuzumab is a humanized | monoclonal antibody. |
| Ocrelizumab is a humanized anti-CD20 | monoclonal antibody. |
| Ramucirumab (IMC-1121B) is a fully human | monoclonal antibody. |
| Afelimomab (MAK 195F) is an anti-TNFα | monoclonal antibody. |
| lly, it is a pegylated F(ab')2 fragment of a | monoclonal antibody. |
| suffix -zumab, it is a recombinant humanized | monoclonal antibody. |
| oposed INN, trade name Numax) is a humanized | monoclonal antibody. |
| d Fab' fragment of a humanized TNF inhibitor | monoclonal antibody. |
| e Nuvion, PDL BioPharma Inc.) is a humanized | monoclonal antibody. |
| (cMT 412) is a human-mouse chimeric anti-CD4 | monoclonal antibody. |
| a single-chain variable fragment of a human | monoclonal antibody. |
| (also called 2C4, trade name Omnitarg) is a | monoclonal antibody. |
| Monoclonal gammopathy of undetermined significance can | |
| Abnormal bands (spikes) are seen in | monoclonal gammopathy of undetermined significance and |
| ith CG due to hematological malignancies and | monoclonal immunoglobulins. |
| Monoclonal paraprotein: In most cases a serum paraprote | |
| sis is sufficient to screen for pathological | monoclonal plasmaproliferative disorders other than AL |
| s, causing self-stimulation and ultimately a | monoclonal population of T cells. |
| light chain are known as paraproteins or M ( | monoclonal) proteins. |
| 864.4020 as “antibodies, both polyclonal and | monoclonal, specific receptor proteins, ligands, nuclei |
| myc, HA), where a | monoclonal was first isolated against an existing prote |
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|